Background: Whole breast radiation therapy (WBRT) is the standard of care for early breast cancer after lumpectomy, but it has side effects. For elderly women with good prognostic cancer, intra-operative radiotherapy (IORT) is an alternative. We report our results with IORT. Methods: We performed a retrospective cohort study to observe clinical outcomes after IORT, between 2012 and 2017. Patients had inclusion criteria for RIOP INCA (French national institute of cancer) (group A) or for TARGIT E (group B).Results: Ninety women were included (91 tumors). The mean age was 73.1 years (range, 56.0-87.0 years) and 95.6% of tumors were under 20 mm. After a median follow-up of 27.4 months (range, 3.0-51.0 months), overall survival was 100%, with two local recurrences out of the 84 tumors followed at least 3 months (2.4%).After IORT, 34.1% of patients had adjuvant WBRT; 70.2% of tumors had fibrosis at least once in the followup, 47.6% had cystosteatonecrosis, 25.8% had breast pain grades 1-2, 6% had over grade 2 toxicities, with no grade 4, and 94.0% had good to very good subjective global aspect.
Conclusions:IORT is a good alternative to WBRT when ASTRO's guidelines indications are respected, with promising results, but need carry on following up with patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.